Time-Tracking-Based Research of Drug Development in Pharmaceutical Fields: A Case Study on Metformin

June 2022 in “ Research Square (Research Square) ”

Shengnan Wu, Jizong Dong, Yidan Sun, Jian Gao, Ruonan Tian, Qi Yu

New to Metformin? There is a guide in the encyclopedia. Read the guide →

metformin androgenic alopecia AMPK hypoglycemic mechanism

Preprint — not peer reviewed. This was posted to a preprint server or data repository. It has not been through a journal's review process, and its findings may change or not hold up.

Studysummary This study revealed that metformin, beyond its hypoglycemic use, may have potential reuse in treating obesity, cardio-cerebrovascular diseases, and more, including possible future applications for Alzheimer's and other conditions.

Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer ·

View this study on researchsquare.com →

Discuss this study in the Community →

Similar Research

5 / 1000+ results

research AMP-activated Protein Kinase 활성체인 Metformin의 모발 성장에 미치는 영향

January 2019 in “대한피부과학회지”

This research found that metformin promoted hair growth in vitro by activating the AMPK/β-catenin signaling pathway in dermal papilla and outer root sheath cells.

research Pituitary Effects of Metformin in Men With Early‐Onset Androgenic Alopecia

May 2022 in “The Journal of Clinical Pharmacology”

This study suggests that metformin has a stronger impact on gonadotroph hormone levels in men with early-onset androgenic alopecia compared to those with normal hair growth.

research Impaired metabolic effects of metformin in men with early-onset androgenic alopecia

4 citations , December 2021 in “Pharmacological Reports”

This study found that metformin's metabolic benefits, such as reducing fat content and improving insulin sensitivity, were less pronounced in men with early-onset androgenic alopecia compared to those with normal hair growth, possibly due to differences in systemic inflammation and vitamin D status.

research Metformin, an Activator of AMPK, Promotes the Growth of Hair Follicles via the AMPK/β-catenin Signaling Pathway

May 2019 in “Journal of Clinical Dermatology”

This study found that metformin, an AMPK activator, promoted hair growth in vitro by enhancing the AMPK/β-catenin signaling pathway in dermal papilla and outer root sheath cells.

Supplementary Material for: Metformin Promotes the Hair-Inductive Activity of Three-Dimensional Aggregates of Epidermal and Dermal Cells Self-Assembled In Vitro

research Supplementary Material for: Metformin Promotes the Hair-Inductive Activity of Three-Dimensional Aggregates of Epidermal and Dermal Cells Self-Assembled In Vitro

January 2021 in “Figshare”

This study found that metformin may promote hair follicle regeneration by enhancing dermal cell activity in an in vitro mouse model, suggesting potential for treating pattern hair loss.